晟德大藥廠股份有限公司
晟德大藥廠股份有限公司（Center Laboratories, Inc.）在台灣及國際市場製造銷售中樞神經及一般感冒用藥。涉及水劑、糖尿病治療、細胞治療及生技產業投資，並經營乳業相關業務。公司成立於 1959 年，總部位於台灣台北。
該股 RSI(6) 為 69.8，處於中性區間，短線無明顯超買超賣訊號。股價站上5日、20日、60日均線，跌破120日均線。短中期均線呈多頭排列，趨勢偏多。KD 指標偏高（K=81.3），追高宜謹慎；MACD 柱狀體為正值，維持多方動能。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-10 | -41 | 0 | +63 | -130 |
| 08-07 | +457 | 0 | +58 | +462 |
| 08-06 | -482 | 0 | +102 | -452 |
| 08-05 | -588 | 0 | +161 | -548 |
| 08-04 | +280 | +205 | +24 | +428 |
| 08-03 | +783 | +380 | +62 | +1,191 |
| 07-31 | +420 | 0 | +34 | +414 |
| 07-30 | -423 | 0 | +33 | -445 |
| 07-29 | +608 | 0 | +79 | +643 |
| 07-28 | +173 | 0 | +4 | +140 |
| 07-27 | +62 | 0 | +51 | +110 |
| 07-24 | -43 | 0 | +10 | -35 |
| 07-23 | -317 | 0 | +131 | -187 |
| 07-22 | -8 | 0 | +69 | +32 |
| 07-21 | -233 | 0 | +15 | -245 |
| 07-20 | +129 | 0 | +20 | +139 |
| 07-17 | +221 | 0 | +1 | +175 |
| 07-16 | +154 | 0 | +17 | +166 |
| 07-15 | +107 | 0 | +33 | +30 |
| 07-14 | -904 | 0 | +49 | -873 |
| 07-13 | -578 | 0 | +4 | -595 |
| 07-09 | -222 | 0 | +1 | -252 |
| 07-08 | -767 | 0 | +4 | -777 |
| 07-07 | +173 | 0 | 0 | +152 |
| 07-06 | +415 | 0 | +34 | +337 |
| 07-03 | +2,499 | 0 | +159 | +2,379 |
| 07-02 | +102 | 0 | +15 | +75 |
| 07-01 | +470 | 0 | 0 | +468 |
| 06-30 | +166 | 0 | +18 | +169 |
| 06-29 | +1,007 | 0 | +40 | +1,026 |
| 06-26 | -343 | 0 | +8 | -349 |
| 06-25 | +1 | 0 | +2 | -1 |
| 06-24 | +1,240 | 0 | +23 | +1,250 |
| 06-23 | +621 | 0 | +7 | +618 |
| 06-22 | -77 | 0 | +2 | -124 |
| 06-18 | -15 | 0 | 0 | -47 |
| 06-17 | -194 | 0 | +103 | -109 |
| 06-16 | -1,520 | 0 | +28 | -1,517 |
| 06-15 | -218 | 0 | +12 | -206 |
| 06-12 | +355 | 0 | 0 | +355 |
| 06-11 | -767 | 0 | +3 | -785 |
| 06-10 | +507 | 0 | +10 | +509 |
| 06-09 | -688 | 0 | +6 | -690 |
| 06-08 | +126 | 0 | +7 | +47 |
| 06-05 | -128 | 0 | +39 | -127 |
| 06-04 | -336 | 0 | +18 | -326 |
| 06-03 | -601 | 0 | +4 | -603 |
| 06-02 | +116 | 0 | +7 | +112 |
| 06-01 | +167 | 0 | +9 | +171 |
| 05-29 | +797 | 0 | +16 | +799 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/04 | 1.77 億 | +19.9% | +28.4% |
| 2026/03 | 1.48 億 | +16.6% | +55.6% |
| 2026/02 | 1.27 億 | -33.7% | -21.1% |
| 2026/01 | 1.91 億 | +27.6% | +56.4% |
| 2025/12 | 1.50 億 | +30.5% | +24.4% |
| 2025/11 | 1.15 億 | -14.7% | -13.4% |
| 2025/10 | 1.35 億 | +3.5% | -31.5% |
| 2025/09 | 1.30 億 | +39.3% | +23.5% |
| 2025/08 | 9346 萬 | -31.2% | -36.7% |
| 2025/07 | 1.36 億 | +20.2% | -3.3% |
| 2025/06 | 1.13 億 | -11.8% | -6.2% |
| 2025/05 | 1.28 億 | - | -15.1% |